At present, MS is diagnosed based on the dissemination of lesions in time and space4–6, whereas NMOSD is diagnosed both by the clinical history and the presence of serum anti-aquaporin-4 antibody (AQP4-IgG)1,7. The gene discussed is AQP4; the disease is myeloid sarcoma.